How different ways of defining iron deficiency (ID) impact the prevalence estimates of this common disorder among women.
Valneva sells Ixchiq priority voucher for $103m to fuel R&D – Pharmaceutical Technology
Share this article Valneva plans to use the funds from the priority review voucher sale to advance its research and development (R&D) efforts. Image Credit: